Accusations fly as a new coronavirus vaccine candidate enters the race for the $100bn market
Another vaccine has entered the race to cure the world of the coronavirus (COVID-19) pandemic, but unlike the US version, when AstraZeneca, in conjunction with a research team in Oxford, announced its successful preliminary trial results the company’s shares plummeted in trading on November 22. Whe»»»
Have anything to say about this article?
You can report: fake news, misinformation, error, more information, additional data, etc.Comment